Google
×
Nov 3, 2008 · Conclusion: Ki-67 LI is confirmed as a prognostic factor in this study. High Ki-67 LI levels may identify a patient group that particularly ...
The nuclear protein Ki-67, present in cycling cells, is an indicator of tumor proliferation and has been found to be a prognostic marker in breast cancer.
Sep 22, 2016 · Ki-67 LI is confirmed as a prognostic factor in this study. High Ki-67 LI levels may identify a patient group that particularly benefits from initial Let ...
People also ask
PDF | To evaluate the prognostic and predictive value of Ki-67 labeling index (LI) in a trial comparing letrozole (Let) with tamoxifen (Tam) as adjuvant.
Ki-67 response after short-term neoadjuvant tamoxifen is a good predictor of recurrence-free survival and overall survival.
Oct 22, 2015 · Tumors having low PgR and/or high Ki-67 have worse prognosis and thus potential for larger absolute benefit of exemestane+OFS versus tamoxifen+ ...
In conclusion, our findings indicate that Ki-67 LI response after short-term presurgical tamoxifen is a better predictor of invasive disease-free survival and ...
Nov 30, 2020 · The trial confirmed the low risk of recurrence for those with a low baseline Ki67. In patients with a high baseline Ki67 value (>10%) a biopsy 2 ...
Jun 15, 2009 · Prognostic and predictive value of centrally reviewed Ki-67 labeling index in post-menopausal women with endocrine-responsive breast cancer: ...
Prognostic and predictive value of centrally reviewed Ki-67 labeling index in postmenopausal women with endocrine-responsive breast cancer: results from Breast ...